Respiratory syncytial virus (RSV), also known as human respiratory syncytial virus (hRSV) is a negative sense RNA virus that infects the respiratory tract. It circulates annually, peaking late fall to early spring, and infection does not produce protective immunity. RSV is the most common cause of respiratory hospitalizations for infants worldwide. It is estimated to cause over 64 million respiratory infections globally each year, resulting in 160,000 deaths.

RSV is divided into two antigenic subtypes A and B, which can circulate at the same time. At Eliteimmune, we have expertise in growing these viruses and offer a range of antiviral assays and reagents to facilitate the study of A (A2, Long) and B strains (9320, WV-14617-85, and 18537). Our RSV microneutralization assay is ideal for investigating the potency of antiviral compounds, and our reagent program offers a variety of research tools for ELISA, multiplex assays, western blots and SDS-PAGE. Contact us today to discuss your research needs.